Vera Therapeutics is trading 4.25% down at $33.78 as broad risk-off pressure weighed on U.S. equities on September 9, 2026.

  • No clear company-specific catalyst was identified; the latest listed press release was dated September 4.
  • Broader markets declined amid higher oil prices and U.S.-Iran tensions: the S&P 500 fell 0.47%, Nasdaq 0.58%, and Dow 0.73%, providing the most likely explanation.